当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
State-of-the-Art Review: Use of Antimicrobials at the End of Life
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2024-02-01 , DOI: 10.1093/cid/ciad735
Daniel Karlin 1 , Christine Pham 2, 3 , Daisuke Furukawa 4 , Ishminder Kaur 5 , Emily Martin 1 , Olivia Kates 6 , Tara Vijayan 2
Affiliation  

Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-centered care and engaging in shared decision making. ID physicians, who often see patients in both inpatient and outpatient settings and maintain continuity of care for patients with refractory or recurrent infections, are ideally situated to provide guidance that aligns with patients’ goals and values. Complex communication skills, including navigating difficult emotions around end-of-life care, can be used to better direct shared decision making and assist with antibiotic stewardship.

中文翻译:

最先进的评论:生命终结时抗菌药物的使用

对于传染病 (ID) 医生来说,在生命临终时使用抗生素是一项挑战,他们仍然坚定地致力于提供以患者为中心的护理并参与共同决策。感染性疾病医生经常在住院和门诊环境中看诊患者,并对难治性或复发性感染的患者保持连续性护理,他们非常适合提供符合患者目标和价值观的指导。复杂的沟通技巧,包括应对临终关怀的困难情绪,可以用来更好地指导共同决策并协助抗生素管理。
更新日期:2024-02-01
down
wechat
bug